Gastroenterology strain | Antibiotic associated diarrhea – Prevention
Characteristics
DAILY DOSAGE IN CLINICAL STUDY
20 billion CFU
FUNCTIONALITY
AAD – Antibiotic associated diarrhea – Prevention
Scientific support
Human clinical trials
Lonnermark, E., V. Friman, G. Lappas, T. Sandberg, A. Berggren, and I. Adlerberth. Intake of Lactobacillus Plantarum Reduces Certain Gastrointestinal Symptoms During Treatment With Antibiotics. Journal of Clinical Gastroenterology 44.2 (2010): 106-12.
Gastroenterology strain I Irritable bowel syndrome
Characteristics
DAILY DOSAGE IN CLINICAL STUDY
20 billion CFU
FUNCTIONALITY
IBS – Irritable bowel syndrome
Scientific support
Human clinical trials
Niedzielin, K., H. Kordecki, and B. Birkenfeld. A Controlled, Double-blind, Randomized Study on the Efficacy of Lactobacillus Plantarum 299V in Patients with Irritable Bowel Syndrome. European Journal of Gastroenterology and Hepatology 13.10 (2001): 1143-147.
Nobaek, S., M. L. Johansson, G. Molin, S. Ahrne, and B. Jeppsson. Alteration of Intestinal Microflora Is Associated with Reduction in Abdominal Bloating and Pain in Patients with Irritable Bowel Syndrome. The American Journal of Gastroenterology 95.5 (2000): 1231-238.
Ducrotte, P., P. D. Sawant, and V. Jayanthi. Clinical Trial: Lactobacillus Plantarum 299v (DSM 9843) Improves Symptoms of Irritable Bowel Syndrome. World Journal of Gastroenterology 18.30 (2012): 4012-018.
